Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Crespi

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Pharmacogenetics|February 1, 1993
Characterization of a human cell line expressing high levels of cDNA-derived CYP2D6B W Penman, J Reece, T Smith, et al.
Analytical Biochemistry|August 31, 2000
A high-throughput screen to identify inhibitors of aromatase (CYP19)D M Stresser, S D Turner, J McNamara, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 1, 1997
Coexpression of cytochrome P4502A6 and human NADPH-P450 oxidoreductase in the baculovirus systemL Chen, J T Buters, J P Hardwick, et al.
Pharmacogenetics|January 26, 1999
Detection and characterization of novel polymorphisms in the CYP2E1 geneK S Fairbrother, J Grove, I de Waziers, et al.
Chemical Research in Toxicology|September 1, 1991
A metabolically competent human cell line expressing five cDNAs encoding procarcinogen-activating enzymes: application to mutagenicity testingC L Crespi, F J Gonzalez, D T Steimel, et al.
Clinical Pharmacology and Therapeutics|February 11, 2000
CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: evidence for an allelic variant with altered catalytic activityF Sata, A Sapone, G Elizondo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 30, 2000
Substrate-dependent modulation of CYP3A4 catalytic activity: analysis of 27 test compounds with four fluorometric substratesD M Stresser, A P Blanchard, S D Turner, et al.
Molecular Pharmacology|June 1, 1985
Monoclonal antibody-directed determination of cytochrome P-450 types expressed in a human lymphoblastoid cell lineF K Friedman, R C Robinson, B J Song, et al.
Carcinogenesis|July 1, 1993
Retroviral mediated expression of human cytochrome P450 2A6 in C3H/10T1/2 cells confers transformability by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)H F Tiano, M Hosokawa, P C Chulada, et al.
Carcinogenesis|August 1, 1990
Human cytochrome P450IIA3: cDNA sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1C L Crespi, B W Penman, J A Leakey, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Pharmacogenetics|February 1, 1993
Characterization of a human cell line expressing high levels of cDNA-derived CYP2D6B W Penman, J Reece, T Smith, et al.
Analytical Biochemistry|August 31, 2000
A high-throughput screen to identify inhibitors of aromatase (CYP19)D M Stresser, S D Turner, J McNamara, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 1, 1997
Coexpression of cytochrome P4502A6 and human NADPH-P450 oxidoreductase in the baculovirus systemL Chen, J T Buters, J P Hardwick, et al.
Pharmacogenetics|January 26, 1999
Detection and characterization of novel polymorphisms in the CYP2E1 geneK S Fairbrother, J Grove, I de Waziers, et al.
Chemical Research in Toxicology|September 1, 1991
A metabolically competent human cell line expressing five cDNAs encoding procarcinogen-activating enzymes: application to mutagenicity testingC L Crespi, F J Gonzalez, D T Steimel, et al.
Clinical Pharmacology and Therapeutics|February 11, 2000
CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: evidence for an allelic variant with altered catalytic activityF Sata, A Sapone, G Elizondo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 30, 2000
Substrate-dependent modulation of CYP3A4 catalytic activity: analysis of 27 test compounds with four fluorometric substratesD M Stresser, A P Blanchard, S D Turner, et al.
Molecular Pharmacology|June 1, 1985
Monoclonal antibody-directed determination of cytochrome P-450 types expressed in a human lymphoblastoid cell lineF K Friedman, R C Robinson, B J Song, et al.
Carcinogenesis|July 1, 1993
Retroviral mediated expression of human cytochrome P450 2A6 in C3H/10T1/2 cells confers transformability by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)H F Tiano, M Hosokawa, P C Chulada, et al.
Carcinogenesis|August 1, 1990
Human cytochrome P450IIA3: cDNA sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1C L Crespi, B W Penman, J A Leakey, et al.
Pageof 10